zonisamide has been researched along with Intellectual Disability in 3 studies
Zonisamide: A benzisoxazole and sulfonamide derivative that acts as a CALCIUM CHANNEL blocker. It is used primarily as an adjunctive antiepileptic agent for the treatment of PARTIAL SEIZURES, with or without secondary generalization.
zonisamide : A 1,2-benzoxazole compound having a sulfamoylmethyl substituent at the 3-position.
Intellectual Disability: Subnormal intellectual functioning which originates during the developmental period. This has multiple potential etiologies, including genetic defects and perinatal insults. Intelligence quotient (IQ) scores are commonly used to determine whether an individual has an intellectual disability. IQ scores between 70 and 79 are in the borderline range. Scores below 67 are in the disabled range. (from Joynt, Clinical Neurology, 1992, Ch55, p28)
| Excerpt | Relevance | Reference |
|---|---|---|
| "This study aimed to evaluate the tolerability and efficacy of zonisamide (ZNS) in adult patients with drug-resistant epilepsy and intellectual disability (ID) at our epilepsy centre." | 8.02 | Long-term effects of zonisamide in adult patients with intellectual disability. ( Eck, K; Hamer, H; Kerling, F; Rauch, C; Winterholler, M, 2021) |
| "Zonisamide is a new drug with broad-spectrum antiepileptic activity against partial as well as generalized seizures." | 6.69 | Long-term effects of zonisamide in the treatment of epilepsy in children with intellectual disability. ( Cho, K; Iinuma, K; Kajii, N; Minami, T; Tachi, N, 1998) |
| "This study aimed to evaluate the tolerability and efficacy of zonisamide (ZNS) in adult patients with drug-resistant epilepsy and intellectual disability (ID) at our epilepsy centre." | 4.02 | Long-term effects of zonisamide in adult patients with intellectual disability. ( Eck, K; Hamer, H; Kerling, F; Rauch, C; Winterholler, M, 2021) |
| "Zonisamide is a new drug with broad-spectrum antiepileptic activity against partial as well as generalized seizures." | 2.69 | Long-term effects of zonisamide in the treatment of epilepsy in children with intellectual disability. ( Cho, K; Iinuma, K; Kajii, N; Minami, T; Tachi, N, 1998) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Eck, K | 1 |
| Rauch, C | 1 |
| Kerling, F | 1 |
| Hamer, H | 1 |
| Winterholler, M | 1 |
| Ortiz-Madinaveitia, S | 1 |
| Serrano-Madrid, ML | 1 |
| Conejo-Moreno, D | 1 |
| Sagarra-Mur, D | 1 |
| Jimenez-Corral, C | 1 |
| Gutierrez-Alvarez, AM | 1 |
| Iinuma, K | 1 |
| Minami, T | 1 |
| Cho, K | 1 |
| Kajii, N | 1 |
| Tachi, N | 1 |
1 trial available for zonisamide and Intellectual Disability
| Article | Year |
|---|---|
Long-term effects of zonisamide in the treatment of epilepsy in children with intellectual disability.
Topics: Adolescent; Anticonvulsants; Child; Child, Preschool; Epilepsy; Female; Humans; Infant; Intellectual | 1998 |
2 other studies available for zonisamide and Intellectual Disability
| Article | Year |
|---|---|
Long-term effects of zonisamide in adult patients with intellectual disability.
Topics: Adolescent; Adult; Aged; Anticonvulsants; Female; Humans; Intellectual Disability; Middle Aged; Retr | 2021 |
[Early onset epileptic encephalopathy in a patient with mutation in
Topics: Age of Onset; Amino Acid Substitution; Anticonvulsants; Child, Preschool; Drug Resistant Epilepsy; D | 2017 |